These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3154674)

  • 1. The pharmacology of nisoldipine.
    Knorr A
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):393-402. PubMed ID: 3154674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat isolated working heart.
    Pijl AJ; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):381-7. PubMed ID: 7504127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine.
    Higashino R; Sato R; Jin H; Inoue N; Fukuta Y; Kurimoto T; Tamaki H
    J Cardiovasc Pharmacol; 1997 May; 29(5):624-30. PubMed ID: 9213205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spasmolytic effect of efonidipine hydrochloride in isolated canine coronary artery: comparison with the effects of nifedipine and nisoldipine.
    Jin H; Sato R; Higashino R; Fukuda Y; Kurimoto T; Tamaki H
    Biol Pharm Bull; 1997 Feb; 20(2):196-200. PubMed ID: 9057986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent.
    Thomas G; Chung M; Cohen CJ
    Circ Res; 1985 Jan; 56(1):87-96. PubMed ID: 2578336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of ischemic myocardial dysfunction by nisoldipine in relation to its coronary vasodilating action.
    Umeda M; Saida K
    Jpn J Pharmacol; 1993 May; 62(1):1-7. PubMed ID: 8341023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the negative inotropic properties of nifedipine and nisoldipine using isovolumetric contractile parameters of the rat in vivo].
    Mauser M; Hoffmeister HM; Beyer M; Seipel L
    Z Kardiol; 1994 Jan; 83(1):60-70. PubMed ID: 8147071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is nisoldipine a specific agent in ischemic left ventricular dysfunction?
    Knorr AM
    Am J Cardiol; 1995 Apr; 75(13):36E-40E. PubMed ID: 7726122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
    Langtry HD; Spencer CM
    Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the cardiodepressive effects of nifedipine, isradipine, nisoldipine and felodipine in patients with coronary heart disease].
    Mauser M; Voelker W; Ickrath O; Karsch KR
    Z Kardiol; 1993 Jan; 82(1):17-27. PubMed ID: 8470415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of manidipine and other calcium antagonists on rat renal arcuate arteries.
    Pfaffendorf M; Mathy MJ; van Zwieten PA
    Am Heart J; 1993 Feb; 125(2 Pt 2):571-7. PubMed ID: 8430602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a calcium channel antagonist, Nisoldipine, on the ischemia-induced change of canine sarcolemmal membrane.
    Takahashi K; Kako KJ
    Basic Res Cardiol; 1983; 78(3):326-37. PubMed ID: 6311155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
    Ehring T; Heusch G
    Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats.
    Godfraind T; Kazda S; Wibo M
    Circ Res; 1991 Mar; 68(3):674-82. PubMed ID: 1660358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct vascular and myocardial effects of nisoldipine.
    Kiowski W; Pfisterer M; Burkart F
    Am J Cardiol; 1990 Apr; 65(14):65G-69G. PubMed ID: 2321554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of nifedipine, nisoldipine, and lacidipine on rat isolated coronary small arteries.
    Pfaffendorf M; Mathy MJ; van Zwieten PA
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):496-502. PubMed ID: 7681514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
    Fleckenstein A; Frey M; Zorn J; Fleckenstein-Grün G
    Am J Cardiol; 1989 Nov; 64(17):21I-34I. PubMed ID: 2530884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay k 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction.
    Nienaber CA; Spielmann RP; Aschenberg W; Fehr A; Clausen A; Bleifeld W
    Am J Cardiol; 1987 Oct; 60(10):836-41. PubMed ID: 3661397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of myocardial reperfusion injury by reducing intracellular calcium overloading with dihydropyridines.
    Liu X; Engelman RM; Wei Z; Bagchi D; Rousou JA; Nath D; Das DK
    Biochem Pharmacol; 1993 Mar; 45(6):1333-41. PubMed ID: 8466553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.